Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • BW TV
  • Subscribe to Print

Latest Articles in zydus cadila

Zydus Cadila Gets USFDA Approval To Market Generic Schizophrenia Drug

The drug production will be done at the group's formulation manufacturing facility in the Special Economic Zone (SEZ), Ahmedabad.

Read More

Zydus Cadila's Coronavirus Vaccine ZyCoV-D To Be Used In 7 States Initially

ZyCov-D, which is the first COVID-19 vaccine to be cleared by India's drug regulator for those aged 12 years and above, will only be administered to adults in the seven states as of now, sources said.

Read More

Zydus Cadila Gets USFDA Nod To Market Generic Cancer Drug In US

Decitabine is used to treat myelodysplastic syndromes, certain types of blood or bone marrow cancer.

Read More

Zydus Cadila Gets USFDA Green Signal For Cancer Drug With 180 Days Exclusivity

The company has received approval from the US Food and Drug Administration (USFDA) for the Nelarabine injection 250 MG/50ML, a generic version of Arranon injection.

Read More

Will Offer Free Jabs To Children With 'Specified Co-Morbidities': Apollo

Zydus Cadila's Covid vaccine ZyCoV-D has already received Emergency Use Authorisation from the Drugs Controller General of India (DCGI) in the country and will be administered to those aged 12 years and above.

Read More

Talks On To Make Zydus Cadila's COVID-19 DNA Vaccine Part Of Inoculation Programme: Govt

Zydus Cadila's indigenously-developed needle-free COVID-19 vaccine ZyCoV-D received the Emergency Use Authorisation from the Drugs Controller General of India last month and will be administered to those aged 12 years and above.

Read More

Zydus Cadila Gets USFDA Nod To Market Depression Treatment Drug In US Market

The drug will be manufactured at the group''s formulation manufacturing facility at the SEZ, Ahmedabad, Zydus Cadila noted.

Read More

Zydus Cadila Gets USFDA Nod For Diabetes Medication

Zydus had filed a new drug application (NDA) with the USFDA seeking approval to market Sitagliptin base 25, 50 and 100 mg tablets.

Read More

Zydus Cadila's COVID-19 Vaccine Can Be Available From First Week Of October

Covishield, Covaxin and Sputnik V vaccines are being given to only those above 18 years and unlike ZyCoV-D, which is three-dose, these are administered in two doses.

Read More

Zydus Cadila Gets USFDA Nod For Arthritis Drug With 180-Days Exclusivity

Zydus was the first abbreviated new drug application (ANDA) filer on Tofacitinib extended-release tablets 22 mg and thus holds 180-day exclusivity on this strength

Read More

Hope To Start Supply of ZyCoV-D Vaccine By Mid To End Sept: Zydus Group MD

Asked if the company was considering partnering with other firms to scale up production of its vaccine, Patel said Zydus Cadila is actively looking at ramping up manufacturing both domestically through partnerships and also outside of the country.

Read More

Zydus Cadila Gets USFDA Nod For Breast Cancer Treatment Drug

The group now has 320 approvals and has so far filed over 400 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04.

Read More

Zydus Cadila Gets Tentative Nod From USFDA To Market Cancer Drug

The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad

Read More

Zydus Cadila Applies For Emergency Use Nod For COVID-19 Vaccine

An approval for Zydus' vaccine, ZyCoV-D, would make it the fifth vaccine authorized for use in India, after Moderna, AstraZeneca (AZN.L) and partner Serum Institute of India's Covishield, Bharat Biotech's Covaxin, and Sputnik V developed by Russia's Gamaleya Institute.

Read More

Zydus Cadila Gets USFDA Approval For Generic Cancer Drug

The group now has 319 approvals and has so far filed over 400 abbreviated new drug applications (ANDAs) since the commencement of the filing process in 2003-04

Read More